Health Services Research
Latest posts by Health Services Research (see all)
- Health System Consolidation and Diabetes Care Performance at Ambulatory Clinics - Feb. 08, 2016
- The Method for Performance Measurement Matters: Diabetes Care Quality as Measured by… - Feb. 05, 2016
- A Randomized, Controlled Trial of a Shared Panel Management Program for Small Practices - Feb. 05, 2016
- Risk Adjustment Tools for Learning Health Systems: A Comparison of DxCG and CMS-HCC V21 - Feb. 04, 2016
Background Assessing the real-world comparative effectiveness of common interventions is challenged by unmeasured confounding. Objective To determine whether the mortality benefit shown for drug-eluting stents (DES) over bare metal stents (BMS) in observational studies persists after controls for/tests for confounding. Data Sources/Study Setting Retrospective observational study involving 38,019 patients, 65 years or older admitted for an index percutaneous coronary intervention receiving DES or BMS in Pennsylvania in 2004–2005 followed up for death through 3 years. Study Design Analysis was at the patient level.